William Blair & Company’s Compugen CGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-206,356
Closed -$1.05M 1461
2016
Q4
$1.05M Sell
206,356
-15,968
-7% -$95.6K 0.01% 641
2016
Q3
$1.4M Sell
222,324
-3,400
-2% -$23K 0.01% 571
2016
Q2
$1.46M Sell
225,724
-3,076
-1% -$20.5K 0.01% 528
2016
Q1
$1.28M Sell
228,800
-600
-0.3% -$3.13K 0.01% 555
2015
Q4
$1.47M Sell
229,400
-1,400
-0.6% -$9.18K 0.01% 537
2015
Q3
$1.19M Buy
230,800
+26,650
+13% +$155K 0.01% 701
2015
Q2
$1.42M Sell
204,150
-600
-0.3% -$4.2K ﹤0.01% 1473
2015
Q1
$1.44M Sell
204,750
-300
-0.1% -$2.45K ﹤0.01% 1433
2014
Q4
$1.71M Sell
205,050
-1,100
-0.5% -$8.46K ﹤0.01% 1328
2014
Q3
$1.77M Buy
206,150
+7,700
+4% +$68.3K ﹤0.01% 1299
2014
Q2
$1.78M Buy
198,450
+5,870
+3% +$52.8K ﹤0.01% 1278
2014
Q1
$2.02M Sell
192,580
-17,300
-8% -$191K ﹤0.01% 1197
2013
Q4
$1.88M Buy
209,880
+6,630
+3% +$64.8K ﹤0.01% 1193
2013
Q3
$2.08M Buy
203,250
+14,750
+8% +$115K ﹤0.01% 1124
2013
Q2
$1.02M Buy
+188,500
New +$1.06M ﹤0.01% 1267

Other funds holding CGEN

William Blair & Company's CGEN Position: Q1 2017 in Review

William Blair & Company sold out of Compugen (CGEN) in Q1 2017, closing a stake of 206,356 shares — an estimated $1.05M sold.

William Blair & Company first reported a position in CGEN in Q2 2013 and held it in 15 quarters. The position peaked at $2.08M in Q3 2013. 40 funds tracked by Wall St. Rank hold CGEN as of Q1 2017.

  • William Blair & Company reported no remaining Compugen position as of Q1 2017 after selling out during the quarter.
  • William Blair & Company sold 206,356 Compugen shares in Q1 2017, an estimated $1.05M.
  • William Blair & Company first reported a position in Compugen in Q2 2013 and held it in 15 quarters.
  • William Blair & Company's Compugen position peaked at $2.08M in Q3 2013.
  • 40 funds tracked by Wall St. Rank held Compugen as of Q1 2017.

Based on William Blair & Company's 13F filing for Q1 2017, filed 10 May 2017.